Jtc Employer Solutions Trustee LTD Heron Therapeutics, Inc. Transaction History
Jtc Employer Solutions Trustee LTD
- $1.17 Billion
- Q3 2025
A detailed history of Jtc Employer Solutions Trustee LTD transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Jtc Employer Solutions Trustee LTD holds 6,500 shares of HRTX stock, worth $7,735. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,500
Previous 6,500
-0.0%
Holding current value
$7,735
Previous $13,000
38.46%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
185Shares Held
130MCall Options Held
1.56MPut Options Held
27.1K-
Rubric Capital Management LP New York, NY26.7MShares$31.8 Million1.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.47MShares$10.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$9.91 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$9.34 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$8.31 Million24.86% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $141M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...